EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Innovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism

Marco Zuin, Irene Lang, Romain Chopard, Andrew S P Sharp, Robert A Byrne, Gianluca Rigatelli, Gregory Piazza

JACC: Cardiovascular Interventions · 2024

DOI: 10.1016/j.jcin.2024.07.033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JACC: Cardiovascular Interventions, 2024. Verfasst von Marco Zuin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, University of Ferrara, Ferrara, Italy; Department of Cardio-Thoraco-Vascular Sciences and Public Health, Univer…. Hauptthemen laut MEDLINE: Pulmonary Embolism, Thrombolytic Therapy, Fibrinolytic Agents, Anticoagulants. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although anticoagulation remains the cornerstone treatment for patients with acute pulmonary embolism (PE), catheter-directed therapy (CDT) has generated great interest as an adjunctive option for those presenting with hemodynamic decompensation or high risk for deterioration and in whom systemic thrombolysis has failed or is contraindicated. However, randomized controlled data supporting the efficacy and safety of CDT in addition to antithrombotic therapy in patients with high-risk and intermediate- to high-risk PE compared with anticoagulation and systemic thrombolysis alone are lacking. This paucity of high-quality data hampers guideline recommendations regarding the optimal therapeutic approach in such patients with PE. The aim of the present paper is to critically appraise the current evidence for CDT in patients with high-risk and intermediate- to high-risk PE and to highlight major areas of innovation in the recent literature. In addition, the authors describe unmet clinical and research needs, potential strategies to resolve these knowledge gaps, and pathways for device selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismThrombolytic TherapyFibrinolytic AgentsAnticoagulantsHumansTreatment OutcomeRisk FactorsRisk AssessmentDiffusion of InnovationClinical Decision-MakingCatheterization, PeripheralHemodynamics

Stichwörter der Autor:innen

catheter-based therapiespulmonary embolismsystemic anticoagulationsystemic thrombolysis

Substanzen

Fibrinolytic AgentsAnticoagulants

Autor:innen und Institutionen

  • Department of Translational Medicine, University of Ferrara, Ferrara, Italy; Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Ferrara, Ferrara, Italy. Electronic address: zuinml@yahoo.it.
  • Clinical Division of Cardiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.
  • Department of Cardiology, University Hospital Jean Minjoz, Besançon, France.
  • Department of Cardiology, University Hospital of Wales and Cardiff University, Cardiff, United Kingdom.
  • Cardiovascular Research Institute Dublin and Department of Cardiology, Mater Private Network, Dublin, Ireland; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Irela…
  • Department of Cardiology, Ospedali Riuniti Padova Sud, Schiavonia, Padova, Italy.

Zitieren

APA

Zuin, M., Lang, I., Chopard, R., Sharp, A. S. P., Byrne, R. A., Rigatelli, G., & Piazza, G. (2024). Innovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.07.033

Vancouver

Zuin M, Lang I, Chopard R, Sharp ASP, Byrne RA, Rigatelli G, et al. Innovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism. JACC: Cardiovascular Interventions. 2024. doi:10.1016/j.jcin.2024.07.033

BibTeX
@article{Zuin2024,
  author = {Zuin, Marco and Lang, Irene and Chopard, Romain and Sharp, Andrew S P and Byrne, Robert A and Rigatelli, Gianluca and Piazza, Gregory},
  title = {Innovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism},
  journal = {JACC: Cardiovascular Interventions},
  year = {2024},
  doi = {10.1016/j.jcin.2024.07.033}
}
Kostenlos starten →